Buy Kinogen Se Injection 50ml Online: The Definitive Veterinary Guide to Muscle Eutrophic Therapy, Selenium Antioxidant Defense, and Metabolic Conditioning in Performance Equines and Camels
In elite animal sports—such as professional thoroughbred racing, endurance events, and competitive camel racing—the physiological strain placed on skeletal muscle networks is immense. During high-intensity sprints or long-distance trials, rapid cellular energy generation triggers a massive release of harmful free radicals and reactive oxygen species (ROS) within the muscle fibers. If the animal’s natural antioxidant systems are overwhelmed or depleted, these unstable molecules cause extensive oxidative cell damage.
This cellular breakdown leads directly to exercise intolerance, persistent muscle soreness, sub-optimal performance, and exertional rhabdomyolysis—commonly known as tying-up syndrome.
Traditional vitamin supplements often fail to provide the immediate, targeted protection required during peak competitive cycles due to variable intestinal absorption rates.
To shield muscle tissue and optimize cellular metabolism under heavy stress, veterinarians and elite trainers rely on targeted injectable eutrophics. Kinogen SE Injection50ml is a premier sterile formulation engineered as a powerful muscle stimulant and energetic eutrophic (tissue-nourishing agent). Combining a high-purity matrix of cellular energy precursors with bioavailable Selenium, Kinogen Se acts directly within the muscle fibers to neutralize destructive oxidative compounds, accelerate cellular waste clearance, and sustain peak mechanical power through the finish line.
This comprehensive reference manual details the molecular pharmacology, cellular pathways, targeted animal indications, and precise clinical protocols for Kinogen SE Injection 50ml.
1. Molecular Pharmacology & Mechanism of Action
Kinogen SE Injection functions via dual, highly integrated metabolic and antioxidant pathways to maintain skeletal muscle integrity:
[Kinogen SE Injection 50ml Injection Administered]
|
[Rapid Systemic Vascular & Muscle Entry]
|
-------------------------------------------------
| |
[METABOLIC ENERGETICS] [ANTIOXIDANT DEFENSE]
(Adenosine Precursor Mix) (Bioavailable Selenium)
| |
v v
[Stimulates Mitochondrial ATP] [Activates Glutathione Peroxidase]
| |
(Drives Aerobic Krebs Cycle) (Neutralizes Destructive Peroxides)
| |
v v
[Delays Intramuscular Fatigue] [Insulates Cellular Membranes]
| |
------------------------> <----------------------
|
v
[Prevention of Tying-Up (Rhabdomyolysis)]
|
[Accelerated Post-Race Muscle Fiber Repair]
Cellular Energetics and ATP Resynthesis
Kinogen SE Injection supplies concentrated, highly bioavailable nucleotide and cofactor precursors that act directly within the cellular mitochondria. By boosting the efficiency of the Krebs Cycle, it accelerates the resynthesis of Adenosine Triphosphate (ATP), the primary energy currency of active muscle fibers. This targeted metabolic support allows working muscles to sustain high-efficiency aerobic contractions longer, delaying the transition to anaerobic metabolism and reducing toxic lactic acid accumulation.
Selenium-Driven Antioxidant Shielding
Skeletal muscle tissues require adequate levels of selenium to build vital defensive enzymes. Kinogen SE Injection addresses this need by providing concentrated elemental selenium:
Enzyme Activation: It acts as a mandatory cofactor for the production of Glutathione Peroxidase (GSH-Px), an essential internal antioxidant enzyme.
Peroxide Neutralization: Glutathione Peroxidase actively converts harmful lipid peroxides and hydrogen radicals into harmless water molecules before they can degrade the cell membrane. This protection prevents muscle enzyme leakage (such as Creatine Kinase) and stabilizes the structural integrity of the muscle fibers.
2. Core Veterinary Clinical Applications
Kinogen SE Injection 50ml is a high-impact therapeutic tool utilized across major performance and companion animal sectors:
Tying-Up Syndrome Management: Used routinely as an effective preventative strategy and treatment for horses and camels prone to post-exercise muscle stiffness or exertional rhabdomyolysis.
Enzymatic Myopathy Rehabilitation: Helps restore normal baseline muscle parameters in animals showing elevated Creatine Kinase (CK) and Aspartate Aminotransferase (AST) blood values.
White Muscle Disease Prophylaxis: Administered to livestock and young calves to prevent nutritional muscular dystrophy caused by selenium-deficient pastures.
Pre-Event Conditioning: Given during the final weeks leading up to intense competitions or long-distance transport to insulate muscle networks against stress.
3. Recommended Administration and Dosing Protocols
To guarantee proper therapeutic expression and animal safety, Kinogen SE Injection 50ml must be administered following strict clinical guidelines.
Veterinary Dosing Reference Table
The table below outlines standard clinical dosing protocols for Kinogen Se 50ml:
| Target Performance Class | Average Weight Range | Recommended Volume Dose | Approved Injection Routes | Administration Frequency |
| Performance Horses | 450 to 550 kg | 15.0 mL to 20.0 mL | Intramuscular (IM) or Slow IV | Every 3 to 4 days for a series of 4–5 injections. |
| Racing Camels | 400 to 500 kg | 10.0 mL to 15.0 mL | Intramuscular (IM) or Slow IV | Every 3 to 4 days during intensive training blocks. |
| Calves / Foals | 100 to 150 kg | 5.0 mL to 7.5 mL | Intramuscular (IM) Only | Single dose; repeat weekly if clinically indicated. |
| Sheep & Goats | 40 to 60 kg | 2.0 mL to 3.0 mL | Intramuscular (IM) Only | Single dose to treat selenium deficiencies. |
4. Clinical Safety, Toxicity Precautions, and Storage
Avoid Overdosing (Selenium Toxicity): Selenium carries a narrow therapeutic margin. Strictly adhere to the recommended weight-based dosing parameters. Signs of acute selenium toxicity (selenosis) include respiratory distress, mild muscle trembling, sweating, and a rapid heart rate. Discontinue use immediately if these signs appear.
Vascular Delivery Speed: When administering via the intravenous path, inject the solution slowly to prevent temporary dizziness or transient blood pressure changes.
Anti-Doping Regulations: Kinogen Se contains metabolic cofactors and selenium, which are natural components of animal physiology. However, because international racing authorities (such as the FEI or IFHA) frequently update pre-event screening rules for trace elements, check local regulations regarding withholding windows before competition days.
Storage Parameters: Store the amber glass bottle upright inside its original carton to protect the solution from direct light. Keep in a cool, dry environment between 15°C and 25°C, and protect from freezing. Use the remaining contents within 28 days of the first needle puncture.
5. Frequently Asked Questions (FAQ)
What is the primary difference between Kinogen SE Injection and standard vitamin E/selenium mixes?
Kinogen SE Injection includes advanced nucleotide metabolic precursors alongside bioavailable selenium. This dual-action design not only provides crucial antioxidant protection but also actively stimulates mitochondrial ATP production, boosting immediate energy levels within the muscle tissue.
Can Kinogen SE Injection be safely mixed with other performance supplements in the same syringe?
No. Kinogen SE Injection is a precisely balanced chemical formulation. Mixing it directly with other compounds, vitamins, or antibiotics inside the same syringe can cause chemical incompatibility or inactivation.
How many days before a major race should the last injection be given?
For optimal performance support, the final conditioning dose of the series is typically administered 24 to 48 hours prior to the race, allowing the active ingredients to achieve maximum cellular storage inside the muscle tissue.
Where can I buy genuine Kinogen SE Injection online?
You can safely purchase authentic, factory-sealed Kinogen Se Injection 50ml online directly through Pet Well Global. We store and manage all inventory under strict environmental controls to guarantee absolute sterility and full therapeutic potency.
6. Secure Performance Logistics from Pet Well Global
At Pet Well Global, we understand that high-performance animal sports demand elite quality control. Every batch of Kinogen Se Injection 50ml is managed within our modern, temperature-regulated facility to ensure full stability and complete clinical value upon delivery to your stable or clinic.
Kinogen SE Injection 50ml is an energetic and muscle reconstituent, hematopoietic and non-hormonal anabolic. It gives the muscle oxigenation requested by high competition delaying tiredness, fatigue and increasing the sport performance. and offer a huge discount for bulk buyers. Packaging and shipping are very discrete and bypass all custom or law enforcement. Delivery through regular and express airmail within 2-3 business days from dispatch. Kinogen SE Injection 50ml
For more information or a special quotation, do not hesitate to
Analgesic, anti-inflammatory and anti-pyretic effect indicated in the treatment of locomotor system diseases.
COMPOSITION:
Phenylbutazone 200 mg
Dexamethasone 0.25 mg
Excipient q.s. 1 ml
INDICATIONS:
Treatment of primary locomotor system diseases. Coadjutant treatment to the antibiotic therapy in infectious arthritis. Treatment of inflammatory processes in osteopathies, adenopathies, neuropathies, mastitis. To control congestive and painful symptoms associated to these processes.
TARGET SPECIES:
Horses, dogs and cats.
ADMINISTRATION ROUTE:
Intramuscular or intravenous.
POSOLOGY:
WITHDRAWAL PERIOD: No withdrawal period. Do not administrate to horses if their meat will be used for human consumption.
reatment of primary locomotor system diseases. Coadjutant treatment to the antibiotic therapy in infectious arthritis. Treatment of inflammatory processes in osteopathies, adenopathies, neuropathies, mastitis. To control congestive and painful symptoms associated to these kinogen 50ml
Analgesic, anti-inflammatory and anti-pyretic effect indicated in the treatment of locomotor system diseases.
COMPOSITION:
Phenylbutazone 200 mg
Dexamethasone 0.25 mg
Excipient q.s. 1 ml
INDICATIONS:
Treatment of primary locomotor system diseases. Coadjutant treatment to the antibiotic therapy in infectious arthritis. Treatment of inflammatory processes in osteopathies, adenopathies, neuropathies, mastitis. To control congestive and painful symptoms associated to these processes.
TARGET SPECIES:
ADMINISTRATION ROUTE:
Intramuscular or intravenous.
POSOLOGY:
Horses: Adult animals: 30 ml/day 1st day, 20 ml/day 2nd day, and subsequently 10 ml/day, during 4-6 days.
Foals: 10 ml/day 1st day and 5 ml subsequent 4-6 days.
Pets: 1 ml/15 kg b.w. per day, during 5 days
WITHDRAWAL PERIOD: No withdrawal period. Do not administrate to horses if their meat will be used for human consumption.
reatment of primary locomotor system diseases. Coadjutant treatment to the antibiotic therapy in infectious arthritis. Treatment of inflammatory processes in osteopathies, adenopathies, neuropathies, mastitis. To control congestive and painful symptoms associated to theseKinogen SEÂ 50ml i

Reviews
There are no reviews yet.